Security National Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Security National Trust’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$322K	Hold	500	–	–	0.07%	137
2021 Q2	$322K	Hold	500	–	–	0.07%	142
2021 Q1	$286K	Buy	+500	New	+$296K	0.07%	140
2020 Q4	–	Sell	-500	Closed	-$258K	–	411
2020 Q3	$258K	Hold	500	–	–	0.07%	138
2020 Q2	$226K	Buy	500 +100	+25%	+$44.1K	0.07%	143
2020 Q1	$140K	Hold	400	–	–	0.05%	160
2019 Q4	$148K	Hold	400	–	–	0.04%	182
2019 Q3	$133K	Hold	400	–	–	0.04%	180
2019 Q2	$125K	Hold	400	–	–	0.04%	187
2019 Q1	$122K	Hold	400	–	–	0.04%	188
2018 Q4	$93K	Hold	400	–	–	0.03%	197
2018 Q3	$125K	Buy	+400	New	+$124K	0.04%	194

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Security National Trust's BIO Position: Q3 2021 in Review

Security National Trust held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2021 at 500 shares worth $322K. The position accounts for 0.07% of the portfolio, ranked #137.

Security National Trust first reported a position in BIO in Q3 2018 and has held it in 12 quarters since. 508 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

Security National Trust held 500 shares of Bio-Rad Laboratories Class A worth $322K as of Q3 2021.
Security National Trust left its Bio-Rad Laboratories Class A share count unchanged in Q3 2021.
Bio-Rad Laboratories Class A made up 0.07% of Security National Trust's portfolio in Q3 2021, its #137 holding.
Security National Trust first reported a position in Bio-Rad Laboratories Class A in Q3 2018 and has held it in 12 quarters since.
508 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.